Florian Kern

4PUBLICATIONS
38CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 23, 2023
The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread.

A C Gomes, I A Baraniak, A Lankina

|Sep 01, 2021
Cross-reactive CD4<sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.

Lucie Loyal, Julian Braun, Larissa Henze

|Mar 27, 2021
Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.

Pavlo Holenya, Paul Joris Lange, Ulf Reimer

|Jul 30, 2020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.

Julian Braun, Lucie Loyal, Marco Frentsch

Pageof 1

Frequent Collaborators

2 joint publications

Victor M Corman

2 joint publications

Leif-Erik Sander

2 joint publications

Claudia Giesecke-Thiel

2 joint publications

Andreas Thiel